Direct fluconazole disk susceptibility testing for Candida glabrata - positive blood cultures

Sarah Israel, Amichai Perlman, Jacob Moran-Gilad, Maya Korem

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Direct susceptibility testing from blood cultures has been reported to reduce the time interval between a positive blood culture to preliminary reporting of susceptibility and can underpin timely appropriate treatment of candidemia.The aim of this study was to evaluate direct susceptibility testing of Candida glabrata to fluconazole using disk diffusion as compared to the Sensititre YeastOne broth microdilution-based method. We tested 83 isolates recovered from 93 spiked and prospective blood culture bottles. Comparison of the two methods showed excellent agreement, with no very major errors and only two major errors (2.4%). The accuracy of the fluconazole disk method was 97.6% (91.6-99.7), with a sensitivity of 100% (95% CI: 82.3-100), and a specificity of 96.9% (95% CI; 89.2-99.6).Direct antifungal disk susceptibility testing from blood cultures is a rapid and easy to perform method to determine fluconazole susceptibility of C. glabrata isolates and can be used safely to reduce susceptibility report time and improve clinical decision making regarding appropriate treatment.

Original languageEnglish GB
Pages (from-to)e0031121
JournalJournal of Clinical Microbiology
Issue number7
StateE-pub ahead of print - 21 Apr 2021


  • Candida glabrata
  • direct disk susceptibility testing
  • fluconazole

ASJC Scopus subject areas

  • Microbiology (medical)


Dive into the research topics of 'Direct fluconazole disk susceptibility testing for Candida glabrata - positive blood cultures'. Together they form a unique fingerprint.

Cite this